Osteoclast formation and bone resorption are inhibited by megakaryocytes.

[1]  M. Scott,et al.  Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL. , 2005, Bone.

[2]  M. Scott,et al.  Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen , 2004, British journal of haematology.

[3]  M. Scott,et al.  Estrogen stimulates differentiation of megakaryocytes and modulates their expression of estrogen receptors α and β , 2004 .

[4]  M. Bouxsein,et al.  Megakaryocyte‐Osteoblast Interaction Revealed in Mice Deficient in Transcription Factors GATA‐1 and NF‐E2 , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  D. Heymann,et al.  Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. , 2003, The American journal of pathology.

[6]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[7]  W. Vainchenker,et al.  Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. , 2003, Blood.

[8]  A. Economides,et al.  0163-769X/03/$20.00/0 Endocrine Reviews 24(2):218–235 Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/er.2002-0023 Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton , 2022 .

[9]  J. Wozney,et al.  Clinical evaluation of recombinant human bone morphogenetic protein-2. , 2002, Clinical orthopaedics and related research.

[10]  J. Thiele,et al.  CD34+ progenitor cells in idiopathic (primary) myelofibrosis: a comparative quantification between spleen and bone marrow tissue , 2002, Annals of Hematology.

[11]  J. Michaeli,et al.  Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Compston,et al.  Megakaryocyte population in human bone marrow increases with estrogen treatment: a role in bone remodeling? , 2000, Bone.

[13]  A. Tefferi.  Myelofibrosis with myeloid metaplasia. , 2000, The New England journal of medicine.

[14]  P. Genever,et al.  Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. , 1999, Blood.

[15]  S. Orkin,et al.  Consequences of GATA-1 Deficiency in Megakaryocytes and Platelets , 1999 .

[16]  S. Morony,et al.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.

[17]  K. Ikeda,et al.  Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells* , 1998, The Journal of Biological Chemistry.

[18]  T. Chambers,et al.  Induction of osteoclast formation by parathyroid hormone depends on an action on stromal cells. , 1998, The Journal of endocrinology.

[19]  B. Boyce,et al.  Estrogen, Transforming Growth Factor-Beta, and the Regulation of Bone Metabolism in Health and Disease , 1998 .

[20]  J. Glowacki,et al.  Expression of an Extracellular Calcium‐Sensing Receptor in Human and Mouse Bone Marrow Cells , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  W. Vainchenker,et al.  High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. , 1997, Blood.

[22]  R. Dubose,et al.  A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function , 1997, Nature.

[23]  N. Tatsumi,et al.  Thrombopoietin inhibits in vitro osteoclastogenesis from murine bone marrow cells. , 1997, Endocrinology.

[24]  S. Mochizuki,et al.  Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. , 1997, Biochemical and biophysical research communications.

[25]  G Shimamoto,et al.  Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.

[26]  S. Orkin,et al.  Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoeitin/MGDF in megakaryocyte development , 1995, Cell.

[27]  D. Thompson,et al.  Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. , 1994, Endocrinology.

[28]  K. Mann,et al.  Characterization of human osteoblast and megakaryocyte-derived osteonectin (SPARC). , 1992, Blood.

[29]  G. Hendy,et al.  Bioactivity of parathyroid hormone and parathyroid hormone-like peptide: agonist and antagonist activities of amino-terminal fragments as assessed by the cytochemical bioassay and in situ biochemistry. , 1991, Endocrinology.

[30]  M. Scott,et al.  Estrogen stimulates differentiation of megakaryocytes and modulates their expression of estrogen receptors alpha and beta. , 2004, Journal of cellular biochemistry.

[31]  Ada Maria Florena,et al.  Value of bone marrow biopsy in the diagnosis of essential thrombocythemia. , 2004, Haematologica.